![Arthur Lieberman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Arthur Lieberman
Plus aucun poste en cours
Historique de carrière de Arthur Lieberman
Anciens postes connus de Arthur Lieberman
Sociétés | Poste | Début | Fin |
---|---|---|---|
TYRX, Inc.
![]() TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ. | Directeur/Membre du Conseil | 26/07/2010 | - |
Formation de Arthur Lieberman
Cornell University | Undergraduate Degree |
Brooklyn Law School | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Director/Board Member | 1 |
Sectorielle
Consumer Services | 3 |
Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
TYRX, Inc.
![]() TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology TYRX, Inc. designs and manufactures medical-pharmaceutical combination devices. The firm commercializes implantable combination drug and device products focused on infection control including the AIGISRx Antibacterial Envelope, designed to reduce surgical site infections associated with cardiac implantable electronic devices (CIEDs). Its AIGISRx products contain the antimicrobial agents, rifampin and minocycline, which have been shown to reduce infection by pathogens responsible for the majority of CIED infections, including superbugs such as methicillin-resistant S. aureus (MRSA). The company was founded in 1998 by Satish Pulapura and Arikha Moses and is headquartered in Monmouth Junction, NJ. | Electronic Technology |
- Bourse
- Insiders
- Arthur Lieberman
- Expérience